iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totaling 7,895 shares, an increase of 158.5% from the July 15th total of 3,054 shares. Based on an average trading volume of 2,182 shares, the days-to-cover ratio is presently 3.6 days. Approximately 5.3% of the shares of the stock are short sold.

iShares Neuroscience and Healthcare ETF Price Performance

IBRN stock opened at $39.10 on Friday. The firm has a market cap of $5.87 million, a PE ratio of 15.61 and a beta of 0.75. iShares Neuroscience and Healthcare ETF has a 12 month low of $24.01 and a 12 month high of $40.42. The firm has a 50 day simple moving average of $37.46 and a 200 day simple moving average of $34.76.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.